Seattle Children's Hospital
New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia
Premium
At AACR, researchers described how pediatric ALL patients who don't respond to anti-CD19 CAR T-cell therapy have cancers with a unique, stem cell-like epigenome.
The GA4K program, run by Children's Mercy Research Institute, aims to build a testing framework for pediatric patients with undiagnosed rare disease.
Illumina, GeneDx Partner With University of Washington on Whole-Genome Sequencing Study in Kids
The SeqFirst study will use whole-genome sequencing to help diagnose critically ill infants and children suspected of having developmental differences.
Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers
Premium
A National Society of Genetic Counselors panel discussed whether healthcare providers are ready for whole-genome sequencing to be adopted as a first-line test.